Hans Eriksson

In this episode of the Psychedelic Medicine Podcast, Dr. Hans Eriksson joins to discuss the potential of non-dissociative ketamine. Dr. Eriksson, Chief Medical Officer at...

In this episode, David Drapkin interviews drug developer, clinical psychiatrist, and Chief Medical Officer at HMNC Brain Health; Dr. Hans Eriksson. HMNC Brain Health is...

In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials...